Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier

Bone Marrow Transplantation

Volumn 20, Issue 7, 1997, Pages 611-612

  Schneider, E ^a   Lambermont, M ^a   Van Vooren, J P ^a   Bastin, G ^a   Feremans, W ^a   Kentos, A ^a   Lemoine, F ^a   Liesnard, C ^a   Delforge, M L ^a   Crenier, L ^a   Capel, P ^a   Farber, C M ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b U Traitement Immunodeficiences   (Belgium)

Author keywords

Acute myeloid leukemia; Autologous peripheral blood stem cell transplantation; HIV

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRUS CARRIER;

EID: 0030695965     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700930     Document Type: Article

References (11)

1. Gabarre J, Leblond V, Sutton L et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 18: 1195-1197.
2. Farber CM, Feremans WW, Capel P et al. Chemotherapy of acute myeloblastic leukemia in an HIV carrier. Eur J Haematol 1993; 51: 180 (letter).
3. Keating MJ, Kantarijian HH, Smith TL et al. Response to a salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 1989; 7: 1071-1080.
4. Vignetti M, Orsini E, Petti MC et al. Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: a single-centre experience. Ann Oncol 1996; 7: 933-938.
5. Gorin NC, Labopin M, Meloni G et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the bone marrow purging by mafosfamide. Leukemia 1991; 5: 896-904.
6. Gorin NC, Dicke K, Lowenberg B. High-dose therapy for acute myelocytic leukemia treatment strategy: what is the choice? Ann Oncol 1993; 4 (Suppl. 1): 59-80.
7. Rowlings PA. 1996 summary slides show current use and outcome of blood and marrow transplantation. ABMTR Newslett 1996; 3: 6-12.
8. Feremans WW, Bastin G, Le Moine F et al. Simplification of the blood stem cell transplantation (BSCT) procedure: large volume apheresis and uncontrolled rate cryopreservation at -8O°C. Eur J Haematol 1996; 56: 278-282.
9. Siena S, Bregni M, Brando W. Flow cytometry for clinical estimation of circulating haematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 343-349.
10. Zauli G, Vitale M, Gibellini D, Capitani S. Inhibition of purified hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J Exp Med 1996; 183: 99-108.
11. Körbling M, Fliedner TM, Holle R et al. Autologous blood stem cell transplantation vs purged bone marrow transplantation in standard risk AML: influence of source and cell composition of the autograft on hematopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343-349.